Go to shop

FAQ

Specific Conjugated Particles are neither nanoparticles nor liposomes. They are neither a variation of any other concept in biophysics or conjugated particles in pharmaceutics. A new entity; stable to be discovered and further to be considered as a viable vehicle for delivery otherwise water-insoluble and biounavailable active ingredients. Our team of clinical and scientific staff is always open to answer any additional questions. Contact US

SCP stands for a hydrolized chemical and physical entity which is sustained and well established in its articled solubility profile. Meaning, stable and secure to achieve and has a long shelf life. Economical to produce as opposed to so-called liposomes and nanoparticles including nano- albumin binding structures; known of NAB. Liposomes and NABs are unstable, low threshold of instability into systemic and GI circulation, very low in accessibility of real structures, etc. SCP has solved these challenges. Our team of clinical and scientific staff is always open to answer any additional questions. Contact US

We have not only a patent, the know- how, but pioneered its chemical manufacturing. Our team of clinical and scientific staff is always open to answer any additional questions. Contact US

We have a great deal of benchmark, manufacturing as well as large-scale data to show that not only a proven track record of mass scale development and production is possible, it process engineering is deemed highly innovative in today's chemical manufacturing compliance world. Our team of clinical and scientific staff is always open to answer any additional questions. Contact US

SCP is a ground-breaking, multi-stage development which has been under development and perfection over the past 14 years by a dedicated team of scientists and clinical professionals at Nexus Alliance Biopharmaceuticals. It's IP and asset ownership is fully managed and owned by Nexus and under licenses via its partner for multiple asset management ownership structure. Our team of clinical and scientific staff is always open to answer any additional questions.Contact US

SCP has a proven track record in 114 products today at the benchmark, and 26 products with first inhuman. Our team of clinical and scientific staff is always open to answer any additional questions.Contact US

SCP may be applied in Neurology, Oncology, Infectious, inflammatory and immune diseases. We have an exceptional level of upshot ambition in other areas. Our team of clinical and scientific staff is always open to answer any additional questions.Contact US

SCP is continuously evolving and has multiple applications into its original IP to avoid compliance of a platform in its application and future possibilities. Our team of clinical and scientific staff is always open to answer any additional questions.Contact US

Cannabis and its extracts are highly water insoluble, low in absorption and adsorption, and limited in its route of delivery as opposed to its active sites of delivery. We have solved that with SCP. Also, we have achieved the most water-soluble, resilient to be delivered into ophthalmic as well as CNS sites of delivery. This is a revolutionary attempt to perfect the art of drug delivery for the targeted sites of interests. Our team of clinical and scientific staff is always open to answer any additional questions.Contact US

Cannabis is a 5000-year-old natural ingredient, used by the ancient medicine to remedy close to 45 known ailments. Our team of clinical and scientific staff is always open to answer any additional questions.Contact US

Currently: Cannabis, cannibis extracts including THC and CBD are not delivered into their needed anatomical sites and the targeted diseased tissues at the minimum ingredient concentration/therapeutic index. Thus, what we smoke, ingest and/or intravenously produced is not achieving the needed amount. We must ingest, smoke, and/or inject more than 15X of the current dose. That is humanly impossible. SCP has resolved this challenge for CBD, THC, and other cannabis extracts per se. Our team of clinical and scientific staff is always open to answer any additional questions.Contact US

SCP has been developed over 14 years with the rough cost of $18M to date. Also, SCP- Cannabis has been under development for the past four years and at an additional rough $6M. SCP- Cannabis is relying on the wealth of knowledge in clinical pharmacology and medicinal chemistry by the team of scientists at Nexus and its joint laboratory development team, under its management of Nexus Alliance Biopharma. SCP- Cannabis technology and its IP is provided to Lior Biosciences to proceed into its late-stage development. Our team of clinical and scientific staff is always open to answer any additional questions.Contact US

We need scientific advisors of great caliber, clinicians of high integrity, as well as investors with value propositions to join our quest in collaboration. Our winning team of scientitists and clinicians are always open to any collaboration at this time. Contact US

Yes, we are proud to show case and pass the test of clinical and scientific value propostion of our products and its clinical evidance. Our team of clinical and scientific staff is always open to answer any level of additional questions.Contact US